Company
Novartis Venture Fund
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Fore Biotherapeutics | Series D-2 | 2026-07-08 | |
| Sidewinder Therapeutics | Series B | 2026-04-09 | Lead |
| Protego Biopharma | Series B | 2025-12-01 | Lead |
| Fore Biotherapeutics | Series D-2 | 2025-05-23 | |
| ONL Therapeutics | Series D Financing | 2024-09-16 | |
| Exsilio Therapeutics | Series A Financing | 2024-06-25 | Lead |
| Capstan Therapeutics | Series B Financing | 2024-03-21 | |
| Fore Biotherapeutics | Series D Financing | 2023-08-25 | |
| Mediar Therapeutics | Funding | 2023-03-15 | Lead |